Semaglutide biosimilar(Hangzhou Zhongmei Huadong)

司美格鲁肽生物类似药（杭州中美华东）

Report date: 2026/04/01 10:58:50

Base Information

Drug NameSemaglutide biosimilar(Hangzhou Zhongmei Huadong)
Drug Alias Namesemaglutida biosimilar(Hangzhou Zhongmei Huadong)索马鲁肽生物类似药（杭州中美华东）semaglutidum biosimilar(Hangzhou Zhongmei Huadong)索玛鲁肽生物类似药（杭州中美华东）Semaglutide Injection(Hangzhou Zhongmei Huadong) +[11] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co LtdHuadong Pharmaceutical (Hangzhou) Bailing Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Pharmaceutical (Hangzhou) Bailing Biotechnology Co LtdChongqing Peg-Bio Biopharm Co LtdHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG